Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term unclassified) Hormone receptors Role: BSU (Biological study-BIOL (Biological study) (Mullerian-inhibiting hormone-type II. Found 1 abstracts

Adams GP, Simmons HH, Yuan Q, Marasco W, Mehta S. Anti-Mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer. 2005 Jul 08;:80 pp.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term unclassified) Hormone receptors Role: BSU (Biological study-BIOL (Biological study) (Mullerian-inhibiting hormone-type II

Uterus (cervix antibody conjugated with Pseudomonas (exotoxin PRP (Properties) Antibodies and Immunoglobulins Role: BPN (Biosynthetic preparation)-THU (Therapeutic use)-BIOL (Biological study)-PREP (Preparation)-USES (Uses) (single chain-Fv-anti-MISIIR Lung anti-Mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer) Diagnosis (cancer unclassified) Toxins Role: BSU (Biological study-BIOL (Biological study) (diphtheria-antibody conjugated with aspirate Mammary gland (nipple Ricins Testis (treatment of Bacteriophage Human unclassified) Proteins Role: BSU (Biological study-BIOL (Biological study) (RIP (ribosome-inactivating protein)-antibody conjugated with Imaging agents cDNA sequences (anti-Mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer) mullerian inhibiting substance receptor MISIIR immunoconjugate human cancer Prostate gland Blood plasma Blood Peptide nucleic acids antibody conjugated with Drug delivery systems (prodrugs Antitumor agents Lung (toxicity Plasmid vectors unclassified) Antibodies and Immunoglobulins Role: BSU (Biological study-THU (Therapeutic use)-BIOL (Biological study)-USES (Uses) (labeled Urine Chemotherapy (antibody conjugated with treatment of Carcinoma (cervix Mammary gland unclassified) Hormone receptors Role: BSU (Biological study-BIOL (Biological study) (Mullerian-inhibiting hormone-type II PRP (Properties) Antibodies and Immunoglobulins Role: BPN (Biosynthetic preparation)-THU (Therapeutic use)-BIOL (Biological study)-PREP (Preparation)-USES (Uses) (anti-MISIIR unclassified) Proteins Role: BSU (Biological study-BIOL (Biological study) (momordins-antibody conjugated with Abrins Testis Ovary Cosmids Gene therapy carcinoma Uterus (cervix-treatment of Radionuclides magnetic Spheres (beads-antibody conjugated with unclassified) Proteins Role: BSU (Biological study-BIOL (Biological study) (PAP (pokeweed antiviral protein)-antibody conjugated with or (MISIIR) immunoconjugates to detect and treat cancer) unclassified) Toxins Role: BSU (Biological study-BIOL (Biological study) (antibody conjugated with anti-Mullerian inhibiting substance type II recep Viral vectors Blood cell Drug delivery systems (immunoconjugates
Last updated on Tuesday, July 07, 2020